Viking Therapeutics (VKTX) Net Shares Issued and Repurchased (2014 - 2026)
Viking Therapeutics (VKTX) posted Net Shares Issued and Repurchased of -$2498.0 for Q3 2014.
Powered by 
Analysis
Viking Therapeutics (VKTX) Net Shares Issued and Repurchased (2014 - 2026) Analysis & Trends
Viking Therapeutics has reported Net Shares Issued and Repurchased for 1 years, with the latest figure at -$2498.0 in Q3 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | - |
| 10 | Viking Therapeutics | 4.01 Bn | 4.01 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 910,896.00 |
| Dec 31, 2025 | 659,033.00 |
| Mar 31, 2025 | 499,145.00 |
| Dec 31, 2024 | 1.22 Mn |
| Mar 31, 2024 | 1.09 Mn |
| Dec 31, 2023 | 1.49 Mn |
| Mar 31, 2023 | 1.34 Mn |
| Dec 31, 2022 | 1.11 Mn |
| Mar 31, 2022 | 1.01 Mn |
| Dec 31, 2021 | 1.08 Mn |
| Sep 30, 2021 | 40,000.00 |
| Jun 30, 2021 | 40,000.00 |
| Mar 31, 2021 | 817,020.00 |
| Dec 31, 2020 | 960,472.00 |
| Mar 31, 2020 | 831,772.00 |
| Dec 31, 2019 | 855,787.00 |
| Mar 31, 2019 | 636,287.00 |
| Dec 31, 2018 | 628,500.00 |
| Mar 31, 2018 | 455,000.00 |
| Dec 31, 2017 | 892,534.00 |